Next Science Future Growth

Future criteria checks 2/6

Next Science is forecast to grow earnings and revenue by 47.6% and 30.6% per annum respectively while EPS is expected to grow by 58.9% per annum.

Key information

47.6%

Earnings growth rate

58.9%

EPS growth rate

Medical Equipment earnings growth16.2%
Revenue growth rate30.6%
Future return on equityn/a
Analyst coverage

Low

Last updated21 Oct 2024

Recent future growth updates

Recent updates

Earnings and Revenue Growth Forecasts

CHIA:NXS - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/202650-2N/AN/A1
12/31/202539-9N/AN/A1
12/31/202428-11N/AN/A1
6/30/202423-14-13-12N/A
3/31/202423-15-14-14N/A
12/31/202322-16-16-15N/A
9/30/202319-15-15-14N/A
6/30/202316-15-14-13N/A
3/31/202314-14-13-13N/A
12/31/202212-13-12-12N/A
9/30/202211-12-12-12N/A
6/30/202210-12-12-11N/A
3/31/202210-11-10-10N/A
12/31/20219-9-9-8N/A
9/30/20218-9-10-9N/A
6/30/20216-9-11-10N/A
3/31/20215-11-12-11N/A
12/31/20203-12-13-12N/A
9/30/20203-12-12-11N/A
6/30/20203-13-11-10N/A
3/31/20203-13-13-11N/A
12/31/20194-14-14-12N/A
9/30/20194-15-14-13N/A
6/30/20194-16-15-14N/A
3/31/20194-15-14-13N/A
12/31/20183-14-13-12N/A
12/31/20174-2N/AN/AN/A
12/31/20161-3N/AN/AN/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: NXS is forecast to remain unprofitable over the next 3 years.

Earnings vs Market: NXS is forecast to remain unprofitable over the next 3 years.

High Growth Earnings: NXS is forecast to remain unprofitable over the next 3 years.

Revenue vs Market: NXS's revenue (30.6% per year) is forecast to grow faster than the Australian market (5.7% per year).

High Growth Revenue: NXS's revenue (30.6% per year) is forecast to grow faster than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if NXS's Return on Equity is forecast to be high in 3 years time


Discover growth companies